Magnesium deficiency in the pathogenesis of mitral valve prolapse

Magnesium
|January 1, 1986
PubMed

Insights

Idiopathic mitral valve prolapse (MVP) is linked to chronic magnesium deficiency (Mg-D), a condition that also causes latent tetany. Magnesium therapy can alleviate MVP symptoms and related complications.

Area of Science:

  • Cardiology
  • Genetics
  • Biochemistry

Background:

  • Idiopathic mitral valve prolapse (MVP) is the most prevalent valvular heart disease in industrialized countries.
  • MVP is primarily a hereditary condition with autosomal dominant inheritance, characterized by variable penetrance.
  • Existing theories suggest MVP arises from a hereditary connective tissue disorder, supported by histopathology and genetic evidence.

Purpose of the Study:

  • To investigate the association between latent tetany (LT) caused by chronic magnesium deficiency (Mg-D) and MVP.
  • To explore how Mg-D may explain clinical manifestations of MVP syndrome not fully accounted for by genetics.
  • To assess the efficacy of magnesium therapy in managing MVP symptoms.

Main Methods:

  • Clinical observation and data analysis of patients with MVP and LT.
  • Biochemical assessment of magnesium levels and fibroblast collagen degradation.
  • Evaluation of catecholamine levels, cardiac arrhythmias, and immune/autonomic nervous system function in relation to Mg-D.

Main Results:

  • Latent tetany (LT) due to chronic magnesium deficiency (Mg-D) is present in over 85% of MVP cases.
  • MVP complicates approximately 26% of LT cases.
  • Mg-D contributes to MVP syndrome by impairing collagen degradation, increasing catecholamines, and disrupting nervous system regulation.

Conclusions:

  • Chronic magnesium deficiency (Mg-D) is strongly associated with idiopathic mitral valve prolapse (MVP).
  • Mg-D provides a unifying explanation for several clinical features of MVP syndrome.
  • Magnesium therapy is effective in relieving symptoms associated with MVP.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...